169 related articles for article (PubMed ID: 38139231)
1. The Profiling of 179 miRNA Expression in Serum from Limb Girdle Muscular Dystrophy Patients and Healthy Controls.
Magri F; Napoli L; Ripolone M; Ciscato P; Moggio M; Corti S; Comi GP; Sciacco M; Zanotti S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139231
[TBL] [Abstract][Full Text] [Related]
2. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
[TBL] [Abstract][Full Text] [Related]
3. Serum miRNAs as biomarkers for the rare types of muscular dystrophy.
Koutsoulidou A; Koutalianos D; Georgiou K; Kakouri AC; Oulas A; Tomazou M; Kyriakides TC; Roos A; Papadimas GK; Papadopoulos C; Kararizou E; Spyrou GM; Zamba Papanicolaou E; Lochmüller H; Phylactou LA
Neuromuscul Disord; 2022 Apr; 32(4):332-346. PubMed ID: 35393236
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
5. Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study.
Doody A; Alfano L; Diaz-Manera J; Lowes L; Mozaffar T; Mathews KD; Weihl CC; Wicklund M; Hung M; Statland J; Johnson NE;
BMC Neurol; 2024 Mar; 24(1):96. PubMed ID: 38491364
[TBL] [Abstract][Full Text] [Related]
6. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
7. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B.
Aguennouz M; Lo Giudice C; Licata N; Rodolico C; Musumeci O; Fanin M; Migliorato A; Ragusa M; Macaione V; Di Giorgio RM; Angelini C; Toscano A
Cell Biochem Funct; 2016 Aug; 34(6):414-22. PubMed ID: 27558075
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
[TBL] [Abstract][Full Text] [Related]
12. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
13. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
14. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-206 as a Biomarker for Patients Affected by Severe Limb Girdle Muscle Dystrophies.
Pegoraro V; Angelini C
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33445560
[TBL] [Abstract][Full Text] [Related]
16. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
17. Serum miRNA Signature in Rheumatoid Arthritis and "At-Risk Individuals".
Cunningham CC; Wade S; Floudas A; Orr C; McGarry T; Wade S; Cregan S; Fearon U; Veale DJ
Front Immunol; 2021; 12():633201. PubMed ID: 33746971
[TBL] [Abstract][Full Text] [Related]
18. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
